Viewing StudyNCT05739227



Ignite Creation Date: 2024-05-06 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 2:52 PM
Study NCT ID: NCT05739227
Status: RECRUITING
Last Update Posted: 2023-02-22
First Post: 2023-02-11

Brief Title: Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting rr B-cell Hematologic Malignancies
Sponsor: Xuzhou Medical University
Organization: Xuzhou Medical University

Conditions & Keywords Data

Conditions:
Name
Chronic Lymphocytic Leukemia
Acute Lymphoblastic Leukemia
B-cell Lymphoma
Keywords:
Name View
B-cell hematologic malignancies View
allogenic CD19-CAR-NK cells View